IIUC, they're not planning to provide a solution but rather a tool with a dashboard and some statistical insights. Even statistical insights could be problematic given how the FDA limited 23andme. Personally the FDA was overly eager, as the 23andme actually gave me some very helpful, if too late, knowledge on my genetic predisposition to an AI condition.
Well depending on how they execute it might be really helpful or not. The per test cost seems fairly high too.